血清脂蛋白Lp(a)浓度不受HMG CoA还原酶抑制剂的影响。 - Suppr

Suppr

超能文献

Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor.

作者信息

Thiery J, Armstrong V W, Schleef J, Creutzfeldt C, Creutzfeldt W, Seidel D

机构信息

Zentrum Innere Medizin, Universitätskliniken, Göttingen.

出版信息

Klin Wochenschr. 1988 May 16;66(10):462-3. doi: 10.1007/BF01745519.

DOI:10.1007/BF01745519

PMID:2969433

Abstract

摘要

相似文献

Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor.血清脂蛋白Lp(a)浓度不受HMG CoA还原酶抑制剂的影响。

Klin Wochenschr. 1988 May 16;66(10):462-3. doi: 10.1007/BF01745519.

Simvastatin and lipoprotein(a).辛伐他汀与脂蛋白(a)。

Lancet. 1992 Feb 1;339(8788):313-4. doi: 10.1016/0140-6736(92)91394-n.

Effects of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase on serum lipoproteins and ubiquinone-10 levels in patients with familial hypercholesterolemia. 1981.

Atheroscler Suppl. 2004 Oct;5(3):51-5. doi: 10.1016/j.atherosclerosissup.2004.08.023.

[A patient with the homozygote form of familial hypercholesterolemia].

Tijdschr Kindergeneeskd. 1991 Jun;59(3):88-91.

[Effects of simvastatin on atherogenic blood lipid pattern].辛伐他汀对致动脉粥样硬化血脂模式的影响

Recenti Prog Med. 1991 Apr;82(4):225-9.

The prediction of the therapeutic response to cholesterol lowering drugs in an 11-year-old boy with homozygous familial hypercholesterolaemia.

J Inherit Metab Dis. 1991;14(3):389-92. doi: 10.1007/BF01811711.

Effects of long-term treatment with simvastatin on plasma lipids and lipoproteins in patients with primary hypercholesterolemia.辛伐他汀长期治疗对原发性高胆固醇血症患者血脂和脂蛋白的影响。

Klin Wochenschr. 1990 Aug 17;68(16):814-22. doi: 10.1007/BF01796271.

Cortisol secretion in patients on simvastatin.服用辛伐他汀患者的皮质醇分泌

Lancet. 1990 Jan 6;335(8680):53. doi: 10.1016/0140-6736(90)90182-5.

Hypolipidemic effects of HMG-CoA reductase inhibitors in patients with hypercholesterolemia.HMG-CoA还原酶抑制剂对高胆固醇血症患者的降血脂作用。

Am J Cardiol. 1987 Oct 30;60(12):33G-42G. doi: 10.1016/0002-9149(87)90589-3.

Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.洛伐他汀和辛伐他汀对家族性高胆固醇血症患者尿中甲羟戊酸排泄的残留影响。

J Lab Clin Med. 2003 Apr;141(4):250-6. doi: 10.1067/mlc.2003.31.

引用本文的文献

The Effects of Extended Release Niacin in Combination with Omega 3 Fatty Acid Supplements in the Treatment of Elevated Lipoprotein (a).缓释烟酸与ω-3脂肪酸补充剂联合使用对治疗高脂蛋白(a)的效果。

Cholesterol. 2010;2010:306147. doi: 10.1155/2010/306147. Epub 2010 Feb 24.

Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).雄激素同化类固醇对载脂蛋白和脂蛋白(a)的影响。

Br J Sports Med. 2004 Jun;38(3):253-9. doi: 10.1136/bjsm.2003.000199.

Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors.3-羟基-3-甲基戊二酰辅酶A还原酶抑制剂的临床药代动力学

Clin Pharmacokinet. 1996 Nov;31(5):348-71. doi: 10.2165/00003088-199631050-00003.

Changes in serum lipoprotein(a) in hyperlipidemic subjects undergoing long-term treatment with lipid-lowering drugs.

Cardiovasc Drugs Ther. 1995 Oct;9(5):677-84. doi: 10.1007/BF00878550.

Clinical features of type III hyperlipoproteinemia: analysis of 64 patients.III型高脂蛋白血症的临床特征：64例患者分析

Clin Investig. 1993 May;71(5):362-6. doi: 10.1007/BF00186624.

Combined therapy with probucol and pravastatin in hypercholesterolaemia. One year follow-up study.普罗布考与普伐他汀联合治疗高胆固醇血症。一年随访研究。

Eur J Clin Pharmacol. 1993;44(6):535-9. doi: 10.1007/BF02440854.

Relation of cardiovascular risk factors to atherosclerosis in type III hyperlipoproteinemia.III型高脂蛋白血症中心血管危险因素与动脉粥样硬化的关系。

Hum Genet. 1993 Sep;92(2):122-6. doi: 10.1007/BF00219678.

Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy.伴有或不伴有糖尿病肾病的2型（非胰岛素依赖型）糖尿病患者中的载脂蛋白(a)与心血管疾病

Diabetologia. 1993 May;36(5):438-44. doi: 10.1007/BF00402281.

Serum LP(A) levels in randomized healthy men from different European countries.来自不同欧洲国家的随机选取的健康男性的血清脂蛋白（a）水平。

Eur J Epidemiol. 1993 Sep;9(5):497-503. doi: 10.1007/BF00209527.

The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans.人类Lp(a)的正常分解代谢不需要低密度脂蛋白受体。

J Clin Invest. 1995 Mar;95(3):1403-8. doi: 10.1172/JCI117794.

本文引用的文献

Diverging effects of cholestyramine on apolipoprotein B and lipoprotein Lp(a). A dose-response study of the effects of cholestyramine in hypercholesterolaemia.消胆胺对载脂蛋白B和脂蛋白Lp(a)的不同作用。消胆胺治疗高胆固醇血症效果的剂量反应研究。

Atherosclerosis. 1982 Jul;44(1):61-71. doi: 10.1016/0021-9150(82)90053-3.

cDNA sequence of human apolipoprotein(a) is homologous to plasminogen.人类载脂蛋白(a)的cDNA序列与纤溶酶原同源。

Nature. 1987;330(6144):132-7. doi: 10.1038/330132a0.

Plasma lipoproteins: teaching old dogmas new tricks.血浆脂蛋白：让旧教条有新花样

Nature. 1987;330(6144):113-4. doi: 10.1038/330113a0.

Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. A multicenter study.

Ann Intern Med. 1987 Nov;107(5):609-15. doi: 10.7326/0003-4819-107-5-609.

Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits.美伐他汀是一种胆固醇合成抑制剂，可诱导仓鼠和兔子肝脏中低密度脂蛋白受体的信使核糖核酸的产生。

Proc Natl Acad Sci U S A. 1986 Nov;83(21):8370-4. doi: 10.1073/pnas.83.21.8370.

Structural relationship of an apolipoprotein (a) phenotype (570 kDa) to plasminogen: homologous kringle domains are linked by carbohydrate-rich regions.载脂蛋白（a）表型（570 kDa）与纤溶酶原的结构关系：同源kringle结构域由富含碳水化合物的区域连接。

Biol Chem Hoppe Seyler. 1987 Dec;368(12):1533-44. doi: 10.1515/bchm3.1987.368.2.1533.

The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels.血清脂蛋白（a）浓度与血管造影评估的冠状动脉粥样硬化之间的关联。对血清低密度脂蛋白水平的依赖性。

Atherosclerosis. 1986 Dec;62(3):249-57. doi: 10.1016/0021-9150(86)90099-7.

Lp(a) lipoprotein as a risk factor for myocardial infarction.脂蛋白(a)作为心肌梗死的一个危险因素。

JAMA. 1986 Nov 14;256(18):2540-4.

Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.脂蛋白Lp(a)水平、血脂及其他脂蛋白与经血管造影证实的冠状动脉疾病的关联。

Circulation. 1986 Oct;74(4):758-65. doi: 10.1161/01.cir.74.4.758.

Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment.脂蛋白Lp(a)的水平在接受新霉素和烟酸治疗后会下降。

Atherosclerosis. 1985 Nov;57(2-3):293-301. doi: 10.1016/0021-9150(85)90041-3.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验